Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Neprilysin
    (2)
  • Endothelin Receptor
    (1)
  • Others
    (8)
TargetMol | Tags By ResearchField
  • Cardiovascular System
    (1)
  • Immune System
    (1)
  • Inflammation
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

nep-in-1

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Recombinant Protein
    7
    TargetMol | Recombinant_Protein
  • NEP-IN-1
    T10918465527-94-0In house
    NEP-IN-1 is an inhibitor of neutral endopeptidase (NEP, IC50 = 2 nM) and can be used in studies about female sexual arousal disorders.
    • $83
    In Stock
    Size
    QTY
  • Sacubitril hemicalcium salt
    AHU377 calcium salt, AHU-377 (hemicalcium salt)
    T42001369773-39-6
    Sacubitril hemicalcium salt (AHU377 calcium salt) is a potent NEP inhibitor with an IC50 of 5 nM. Sacubitril hemicalcium salt is a component of the heart failure medicine LCZ696. Sacubitril hemicalcium salt is a prodrug of LBQ657, which is an inhibitor of the zinc metallopeptidase neprilysin. Neprilysin degrades a variety of vasoactive peptides such as atrial and brain natriuretic peptide, bradykinin, adrenomedullin, and endothelin-1. Inhibition of neprilysin leads to an increased level of these peptides and, thus, antihypertensive effects. Formulations containing AHU377 in combination with the angiotensin II receptor antagonist valsartan are used to treat hypertension and heart failure.
    • $38
    In Stock
    Size
    QTY
  • Daglutril
    SLV-306, SLV306, SLV 306
    T27119182821-27-8
    Daglutril, a NEP/ECE inhibitor, is potentially used for the treatment of hypertension, heart failure andpulmonary. Daglutril inhibits systemic conversion of big endothelin-1 in humans.
    • $1,520
    6-8 weeks
    Size
    QTY
  • NEP(1-40) TFA
    T81685
    NEP(1-40) TFA is a peptide antagonist of the Nogo-66 receptor (NgR), which attenuates myelin-derived inhibition and mitigates injury-induced shifts in microglial morphology distributions [1].
    • Inquiry Price
    Inquiry
    Size
    QTY